Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03898843
Other study ID # 69HCL18_0804
Secondary ID 2018-A02789-46
Status Terminated
Phase N/A
First received
Last updated
Start date September 18, 2020
Est. completion date August 24, 2022

Study information

Verified date May 2023
Source Hospices Civils de Lyon
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Assisted animal therapy (AAT) is getting more and more used worldwide, in such areas as gerontology, psychiatry, or oncology. It is a complementary therapy, and benefits for patients are various, including decrease of anxiety. In ICU, some case reports exist, but no study has ever been made in order to prove its benefits, not even its feasibility. In ReAnimal, the investigator aims to compare a group of patients receiving assisted animal therapy, versus a group of patients not receiving it. Primary objective will be the evolution of anxiety scores between the 2 groups of patients. Secondary objectives will be the comparison of mood scores, post traumatic stress syndrome scores, pain scores, and physiologic parameters such as blood pressure, cardiac frequency. The investigating team will also compare multi drug resistant bacteria incidence between the 2 groups. In the assisted animal therapy group, patients will also be asked to answer a satisfaction questionnaire.


Recruitment information / eligibility

Status Terminated
Enrollment 7
Est. completion date August 24, 2022
Est. primary completion date August 24, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - patients hospitalized in surgical ICU, not in acute stage of their ICU stay - adult patient - able to receive information and to give consent, - with national social insurance Exclusion Criteria: - afraid of animal, dog phobia - allergic to dog - immunodepression (neutrophils <0.5 G/L), induced by treatment (chemotherapy, immunosuppressing treatment with high doses, corticotherapy for more than 2 weeks) or induced by disease (malignant blood disease, AIDS, transplantation, or splenectomy) - sepsis ongoing - patient known for having multidrug resistant bacteria - wounds, or large bandages that could not correctly be covered, including external fixer - central venous catheter, arterial catheter - tracheostomy - agitation, aggressiveness - pregnant women - patient deprived of freedom by juridical or administrative decision - patient under legal protection measure - patient receiving enforced psychiatric treatment - patient admitted in a sanitary or social department.

Study Design


Intervention

Other:
Animal assisted therapy
Patients of AAT group will leave their hospital bedroom to go in the session room, where they will meet a dog, who has come with his veterinary student master. Animal assisted therapy session will last at most 20 minutes, in which the patient is going to interact with the dog, pet him, play with him, etc.
Biological:
Nasal swab sampling
All patients will have nasal swab sampling at inclusion and 7 days after AAT session or sham session in order to screen multidrug resistant bacteria
Behavioral:
STAI-Y and POMS Questionnaires
Before and after AAT or sham session, patients will answer State-Trait Anxiety Inventory Y (STAI-Y), Profile of Mood States (POMS) questionnaires.
Procedure:
physiological parameters measure
Before and after AAT or sham session, blood pressure, heart rate dans respiratory rate will be measured.
Other:
Visual Analog Scale (VAS)
Before and after AAT or sham session, pain will be evaluated thanks to VAS
Behavioral:
Impact of Event Scale - Revised (IES-R)
Patients will answer IES-R questionnaire 3 months after AAT or sham session
satisfaction questionnaire
Patients of the AAT group will answer satisfaction questionnaire at the end of the AAT session and 3 months after AAT
Biological:
Rectal swab sampling
All patients will have rectal swab sampling at inclusion and 7 days after AAT session or sham session in order to screen multidrug resistant bacteria

Locations

Country Name City State
France Hôpital Edouard Herriot - Anesthesiology department Lyon

Sponsors (1)

Lead Sponsor Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary State-Trait Anxiety Inventory Y (STAI-Y) score Self-administered questionnaire, of 20 questions whose answers are either "No", "Rather no" "Rather yes" "Yes". Points calculated are 1 point for each "No" answer, up to 4 points for each "Yes" answer. Thus, score can be at least 20 points, at most 80 points. Before randomization
Primary State-Trait Anxiety Inventory Y (STAI-Y) score Self-administered questionnaire, of 20 questions whose answers are either "No", "Rather no" "Rather yes" "Yes". Points calculated are 1 point for each "No" answer, up to 4 points for each "Yes" answer. Thus, score can be at least 20 points, at most 80 points. 2 days after inclusion, before AAT or sham session
Primary State-Trait Anxiety Inventory Y (STAI-Y) score Self-administered questionnaire, of 20 questions whose answers are either "No", "Rather no" "Rather yes" "Yes". Points calculated are 1 point for each "No" answer, up to 4 points for each "Yes" answer. Thus, score can be at least 20 points, at most 80 points. 2 days after inclusion, after AAT or sham session
Secondary Profile Of Mood States (POMS) score Self-administered questionnaire, of 37 questions, whose answers are either "not at all", "a little", "moderately", "quite a lot", or "extremely". Each adjective in the POMS questionnaire is awarded the following score:
0 - Not at all
1 - A little
2 - Moderately
3 - Quite a Lot
4 - Extremely except "Relaxed" and "Efficient" and they score the reverse:
4 - Not at all
3 - A little
2 - Moderately
1 - Quite a Lot
0 - Extremely Thus, the score can range from 0 up to 148 points.
2 days after inclusion, before AAT or sham session
Secondary Profile Of Mood States (POMS) score Self-administered questionnaire, of 37 questions, whose answers are either "not at all", "a little", "moderately", "quite a lot", or "extremely". Each adjective in the POMS questionnaire is awarded the following score:
0 - Not at all
1 - A little
2 - Moderately
3 - Quite a Lot
4 - Extremely except "Relaxed" and "Efficient" and they score the reverse:
4 - Not at all
3 - A little
2 - Moderately
1 - Quite a Lot
0 - Extremely Thus, the score can range from 0 up to 148 points.
2 days after inclusion, after AAT or sham session
Secondary Blood pressure Physiological parameters noted on the patient usual monitoring in Intensive Care Unit (ICU), which the patient will keep during the whole session. 2 days after inclusion, before AAT or sham session
Secondary Blood pressure Physiological parameters noted on the patient usual monitoring in Intensive Care Unit (ICU), which the patient will keep during the whole session. 2 days after inclusion, after AAT or sham session
Secondary Heart rate Physiological parameters noted on the patient usual monitoring in Intensive Care Unit (ICU), which the patient will keep during the whole session. 2 days after inclusion, before AAT or sham session
Secondary Heart rate Physiological parameters noted on the patient usual monitoring in Intensive Care Unit (ICU), which the patient will keep during the whole session. 2 days after inclusion, after AAT or sham session
Secondary Respiratory rate Physiological parameters noted on the patient usual monitoring in Intensive Care Unit (ICU), which the patient will keep during the whole session. 2 days after inclusion, before AAT or sham session
Secondary Respiratory rate Physiological parameters noted on the patient usual monitoring in Intensive Care Unit (ICU), which the patient will keep during the whole session. 2 days after inclusion, after AAT or sham session
Secondary Visual Analog Scale (VAS) score Pain scale, from 0 = no pain at all, up to 10 = pain at maximum level 2 days after inclusion, before AAT or sham session
Secondary Visual Analog Scale (VAS) score Pain scale, from 0 = no pain at all, up to 10 = pain at maximum level 2 days after inclusion, after AAT or sham session
Secondary Presence of Multi-drug resistant bacteria Nasal and rectal sampling, looking for methicillin resistant staphylococcus aureus in nasal sampling, and multi-drug resistant bacteria in rectal sampling At inclusion
Secondary Presence of Multi-drug resistant bacteria Nasal and rectal sampling, looking for methicillin resistant staphylococcus aureus in nasal sampling, and multi-drug resistant bacteria in rectal sampling 7 days after AAT or sham session
Secondary Impact of Event Scale - Revised (IES-R) score Score for post traumatic stress disease. 22 questions self administered, whose answers are either "not at all", "a little", "moderately", "quite a lot", or "extremely". Each question is awarded score from 0 ("not at all") up to 4 ("extremely"). Thus, the total score ranges from 0 up to 88 points. 90 days after AAT or sham session
Secondary Patient Satisfaction score Only for AAT group 2 days after inclusion, at the end of AAT session
Secondary Patient Satisfaction score Only for AAT group 90 days after AAT session
Secondary Caregiver Satisfaction score 2 days after inclusion, at the end of AAT session
Secondary Caregiver Satisfaction score 90 days after AAT or sham session
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Completed NCT04748367 - Leveraging on Immersive Virtual Reality to Reduce Pain and Anxiety in Children During Immunization in Primary Care N/A
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT04579354 - Virtual Reality (VR) Tour to Reduce Preoperative Anxiety Before Anaesthesia N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Completed NCT03535805 - Transdiagnostic, Cognitive and Behavioral Intervention for in School-aged Children With Emotional and Behavioral Disturbances N/A
Recruiting NCT05956912 - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Active, not recruiting NCT05302167 - Molehill Mountain Feasibility Study. N/A
Completed NCT05588622 - Meru Health Program for Cancer Patients With Depression and Anxiety N/A
Completed NCT05881681 - A Mindfulness Approach to UA for Afro-descendants N/A
Active, not recruiting NCT04961112 - Evaluating the Efficacy of Cranial Electrotherapy Stimulation in Mitigating Anxiety-induced Cognitive Deficits N/A
Terminated NCT04612491 - Pre-operative Consultation on Patient Anxiety and First-time Mohs Micrographic Surgery
Completed NCT05980845 - The Effect Nature Sounds and Music on Hemodialysis Patients N/A
Recruiting NCT05449002 - Digital Single Session Intervention for Youth Mental Health N/A
Completed NCT05585749 - Virtual Reality Application on Pain Intensity and Anxiety Level in Endoscopy Patients N/A
Terminated NCT03272555 - WILD 5 Wellness: A 30-Day Intervention N/A
Recruiting NCT05997849 - Development of a Multiplatform Mental Health Mobile Tool N/A
Completed NCT06421233 - The Effect of Endorphin Massage Applied to Postpartum Women on Anxiety and Fatigue Levels N/A